As expected, all “Control” specimens were negative for both pathologic proteins, whereas the AD group yielded significantly elevated levels of Aβ and PHF-tau (two-tailed t-test P < 0.001) consistent with the molecular manifestation of Alzheimer′s disease. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.